4TH ANNUAL BREAST CANCER SYMPOSIUM
LIVE IN PERSON AND ONLINE BROADCAST

September 23-25, 2022
Hudson Hall Opera House, Hudson, NY
If you are not already on our email list, click here to be notified when registration opens.

Proudly Hosted By:

EVENT INFORMATION

Registration

Coming Soon!

Program Overview

CONFERENCE PLATFORM

The 3rd Annual Breast Cancer Symposium was held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A discussions. The conference is being offered on-demand until October 30th.

Educational Goal

Breast cancer is a multifaceted disease and the second most common cancer among women in the United States. Advances in the ability to tailor an individual patient’s diagnosis, management, and treatment have been growing exponentially during the last twenty years. The identification of novel therapeutic strategies has also led to improved surgical and radiation outcomes. Actionable targets have identified smarter systemic therapies with improved, disease-free, overall survival benefits. In addition to awareness, addressing the health, emotional, and physical well-being of patients after breast cancer treatment has improved the overall quality of life for the patient and their families. The goal of this conference is to educate the medical and global community and foster communication that will benefit the individual patient as well as the community.

TARGET AUDIENCE

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Review the modern surgical approaches addressed in the patient encounter

Discuss updates in breast cancer imaging for earlier detection

Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing and triple negative breast cancer

Review advances in radiation therapy and outcomes

Identify risk factors and endocrine interventions in patients high risk for developing breast cancer

Discuss the role of hereditary genetics and the implication to the patient and their families

DOWNLOAD AGENDA

Planning Committee

Maria Theodoulou, MD (Course Chair & Moderator)
Program Director
Breast Cancer Medicine
New York Oncology Hematology
Albany, NY

Todd Doyle, MD
President, NYOH
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

FACULTY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
President and Director of Research, Sass Foundation for Medical Research
Lake Success, NY

Andrea V. Barrio, MD, FACS
Associate Attending, Breast Surgical Service,
Memorial Sloan Kettering Cancer Center
Associate Professor of Surgery, Weill Cornell Medical College
New York, NY

Dr. Anna Boguniewicz M.D.
Associate Professor
Director, Pathology Residency Training Program
Department of Pathology and Laboratory Medicine
Albany Medical Center
Albany, NY

Dr. Edi Brogi M.D., Ph.D.
Director of Breast Pathology and Attending Pathologist
Memorial Sloan Kettering Cancer Center
Professor of Clinical Pathology and Laboratory Medicine
Weill Cornell Medical College
New York, NY

Chau T. Dang, MD
Medical Director, MSK Westchester Medical Oncology
Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, NY

Joseph J. Disa, MD, FACS
Attending Plastic Surgeon
Vice Chair of Clinical Activities, Department of Surgery
Benno C. Schmidt Chair in Surgical Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Mary L. Gemignani, MD, MPH, FACS
Attending, Breast Service, Department of Surgery
Director, Breast Surgical Fellowship Program
Professor of Surgery, Weill Cornell Medical College
New York, NY

Yasmin Hasan, MD
Associate Professor
Department of Radiation and Cellular Biology
Residency Program Director
Director of Gynecological Brachytherapy
University of Chicago Medical Center
Chicago, IL

Dr. Clifford A. Hudis, MD, FACP, FASCO
Chief Executive Officer,
American Society of Clinical Oncology
Alexandria, VA

Claudine Isaacs, MD
Professor of Medicine and Oncology
Associate Director, Clinical Research
Leader, Clinical Breast Cancer Program
Georgetown University
Washington, DC

Neil Iyengar, MD
Assistant Attending
Memorial Sloan Kettering Cancer Center
Associate Attending
Rockefeller University
Assistant Professor of Medicine
Weill Cornell Medicine
New York, NY

Justin Juliano, MD
Radiation Oncologist
NYOH Clifton Park
Clifton Park, NY

Eleftherios (Terry) Mamounas, MD, MPH
Medical Director, Comprehensive Breast Program
Orlando Health UF Health Care Center
Professor of Surgery
University of Central Florida
Orlando, FL

Dr. Heather McArthur
Clinical Director of Breast Cancer and Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern
Dallas, TX

Dr. Ahmed Meleis, MD
Assistant Professor of Neurological Surgery
Department of Neurosurgery, Albany Medical Center
Albany, NY

Dr. Shanu Modi, MD
Associate Member, Section Head HER2 Breast Program
Memorial Sloan Kettering Cancer Center
Associate Professor
Weill Cornell Medical College
New York, NY

Elizabeth Morris, MD
Chair, Department of Radiology
Professor, Department of Radiology
UC Davis Health
Sacramento, CA

Hyman B. Muss, MD
Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Professor of Medicine, University of North Carolina
Director of Geriatric Oncology, Lineberger Comprehensive Cancer Center
Chapel Hill, NC

Dr. Rita Nanda, MD
Associate Professor of Medicine
Director of Breast Oncology
The University of Chicago
Chicago, IL

Larry Norton, MD, FASCO, FAACR
Senior Vice President, Office of the President
Medical Director, Evelyn H. Lauder Breast Center
Deputy Director for Clinical and Translational Science, MSK Comprehensive Cancer Center
Norna S. Sarofim Chair of Clinical Oncology
New York, NY

Dr. Tia Olds, M.D.
Radiation Oncologist
New York Oncology Hematology
Albany, NY

Edith A. Perez, MD
Professor of Medicine
Director, Breast Cancer Translational Genomics Program
Mayo Clinic
Jacksonville, FL

George Plitas, MD
Associate Attending, Breast Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Dennis J. Rassias, M.D., F.A.C.S.
Chief of Thoracic Surgery at St. Peter’s Health Partners
Albany, NY

Mark E. Robson, MD
Chief, Breast Medicine Service
Attending Physician, Breast Medicine and Clinical Genetics Services
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY

Loren L. Rourke, MD, MHCM, FACS
Chief Surgical Officer, US Oncology Network
The Woodlands, TX

Andrew Seidman, MD
Medical Director, Bobst International Center
Attending Physician
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weil Cornell Medical College
New York, NY

Tiffany A. Traina, MD
Vice Chair, Oncology Care, Department of Medicine
Associate Attending Physician
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY

Stephen H. Wrzesinski MD, PhD
Director of Immunooncology and Cellular Therapy and Medical Oncologist, New York Oncology Hematology
Clinical Assistant Professor of Medicine, Albany Medical College
Albany, NY

Maria Theodoulou, MD (Course Director)

Medical Oncologist

New York Oncology Hematology

Albany, NY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Jeanne Carter, PhD
Head, Female Sexual Medicine and Women's Health Program
Memorial Sloan Kettering Cancer Center
New York, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

The 3rd Annual Breast Cancer Symposium: The Seasons of Breast Cancer is being organized in
collaboration with New York Oncology Hematology (NYOH), The University of Chicago Pritzker
School of Medicine, and myMedEd, Inc. With an expanded agenda, this accredited conference
will offer 18.5 continuing education credits and is scheduled to be held September 24-26, 2021
at NYOHbcs.com.
A virtual tradeshow platform is available to exhibitors and offers the opportunity to include a
video presentation, literature, live chat, messaging and the organization’s Twitter feed.
Conference attendees can visit booths and interact with exhibitors during the conference and
the virtual tradeshow will remain live for 30 days following the conference.

To complete the application, please go to https://cmersvp.com/exhibit-processing-form/

If you have questions, email:
exhibits@mymededco.com

HOST

The 3rd annual Breast Cancer Symposium is proudly hosted by New York Oncology Hematology.

ACCREDITATION

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:
It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

The annual Breast Cancer Symposium brings together nationally and internationally known speakers, as well as our regional thought leaders on the holistic care of women with breast cancer. The agenda is delivered by an esteemed faculty in the breast cancer world, who continue to move forward with research from bench to clinic.

Click on the links below to view the programs from years past.

2019 Breast Cancer & Survivorship in the 21^st Century: Less is More, More or Less

2020 Controversies in Breast Cancer: Increasing or Decreasing?

2021 Seasons of Breast Cancer

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible:

AbbVie, Inc.
Ambry Genetics Corporation
American Cancer Society HopeClub
Amgen, Inc.
AstraZeneca US
Biotheranostics, Inc., A Hologic Company.
Boehringer Ingelheim
- Pharmaceuticals, Inc.
Caris Life Sciences
Celgene Corporation
Daiichi Sankyo, Inc.
Eisai Co., Ltd
Genentech, Inc.
Genoptix, A NeoGenomics Company
Gilead Sciences.
GlaxoSmithKline
Guardant Health

Immunomedics
Incyte Corporation
Lilly USA, LLC
Merck & Co., Inc.
Myriad Genetics, Inc.
NeoGenomics Laboratories, Inc.
New York Oncology Hematology
Novartis Oncology
Pfizer Oncology
Pfizer, Inc.
Puma Biotechnology
Sanofi-Genzyme
Seagen
Susan G. Komen® Upstate NY
Teva Pharmaceuticals Industries Ltd.

This Activity Is Planned By myMedEd, Inc.

Accredited Provider:

4TH ANNUAL BREAST CANCER SYMPOSIUM LIVE IN PERSON AND ONLINE BROADCAST

September 23-25, 2022Hudson Hall Opera House, Hudson, NY If you are not already on our email list, click here to be notified when registration opens.